m+Medelevator.RU
← Поиск публикаций
Pediatric pulmonology · 2011

Flexible bronchoscopy as a valuable diagnostic and therapeutic tool in pediatric intensive care patients: a report on 5 years of experience.

СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Peng Yu-Yun, Soong Wen-Jue, Lee Yu-Sheng, Tsao Pei-Chen, Yang Chia-Feng, Jeng Mei-Jy

Аннотация

OBJECTIVE: To evaluate the clinical role of flexible bronchoscopy (FB) in pediatric and neonatal intensive care units (ICUs).

DESIGN: A retrospective review of all patients receiving FB procedures between January 2005 and December 2009.

SETTING: Pediatric and neonatal ICUs of a tertiary care multi-disciplinary teaching hospital located in northern Taiwan.

PATIENTS: A total of 358 ICU patients (223 males) who received 725 FB procedures.

MEASUREMENTS AND MAIN RESULTS: The medical records were reviewed and analyzed. Mean age for the first time FB was 35.7 (±48.9 SD) months old and 68.2% of them were <3 years old. Among them, unexplained retraction or tachypnea (32.0%) and stridor (20.1%) were the two leading indications for FB. The positive finding rate of FB was 87.2%, with airway malacia (47.8%) being the most common, especially in patients <3 years old. Positive lesion sites were approximately equally distributed between the upper (51.1%) and lower (50.6%) airways. Concomitant findings in the esophagus were found in 15.4% of the patients. There were 518 interventional FBs (71.4%, 518/725 procedures) which were performed on 201 (56.1%, 201/358) patients; FB-aided endotracheal intubation (180/518, 34.7%) and laser therapy (109/518, 21.0%) were the two leading techniques used. No patient suffered from any long-term complications or mortality associated with the FB procedures.

CONCLUSIONS: FB is a safe and valuable diagnostic and therapeutic tool for patients in pediatric and neonatal ICUs.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты